Jessica A. Lasky Su, Sc.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genetic Linkage | 8 | 2008 | 2381 | 0.260 |
Why?
|
Metabolome | 1 | 2021 | 982 | 0.230 |
Why?
|
Metabolomics | 1 | 2021 | 1628 | 0.200 |
Why?
|
Fetal Proteins | 1 | 2012 | 97 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 9 | 2012 | 17790 | 0.090 |
Why?
|
T-Box Domain Proteins | 1 | 2012 | 468 | 0.080 |
Why?
|
Linkage Disequilibrium | 2 | 2005 | 1996 | 0.080 |
Why?
|
Schizophrenia | 5 | 2006 | 6915 | 0.080 |
Why?
|
Schizophrenic Language | 1 | 2006 | 57 | 0.070 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2006 | 276 | 0.060 |
Why?
|
Heroin Dependence | 1 | 2006 | 172 | 0.060 |
Why?
|
Interleukin-13 | 1 | 2007 | 371 | 0.060 |
Why?
|
Language Disorders | 1 | 2006 | 139 | 0.060 |
Why?
|
Pedigree | 4 | 2005 | 4578 | 0.060 |
Why?
|
Genome, Human | 3 | 2006 | 4418 | 0.060 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2004 | 286 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2012 | 1869 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2012 | 15790 | 0.050 |
Why?
|
Quantitative Trait, Heritable | 1 | 2005 | 540 | 0.050 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2004 | 363 | 0.050 |
Why?
|
Enzymes | 1 | 2004 | 261 | 0.050 |
Why?
|
Eosinophilia | 1 | 2007 | 559 | 0.050 |
Why?
|
Asthma | 3 | 2012 | 6172 | 0.050 |
Why?
|
Chromosomes, Human | 1 | 2004 | 442 | 0.050 |
Why?
|
Receptors, Immunologic | 1 | 2008 | 1414 | 0.050 |
Why?
|
Chromosome Mapping | 3 | 2006 | 4626 | 0.050 |
Why?
|
Immunoglobulin E | 1 | 2007 | 1484 | 0.050 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2803 | 0.040 |
Why?
|
Receptors, Nicotinic | 1 | 2004 | 494 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2004 | 724 | 0.040 |
Why?
|
Glycolysis | 1 | 2004 | 828 | 0.040 |
Why?
|
Databases, Genetic | 1 | 2005 | 1738 | 0.040 |
Why?
|
Point Mutation | 1 | 2004 | 1594 | 0.040 |
Why?
|
Cooperative Behavior | 1 | 2005 | 1500 | 0.040 |
Why?
|
Family | 2 | 2005 | 3189 | 0.040 |
Why?
|
Bipolar Disorder | 2 | 2004 | 5078 | 0.040 |
Why?
|
Genome | 1 | 2004 | 1739 | 0.030 |
Why?
|
Genetic Testing | 2 | 2008 | 3531 | 0.030 |
Why?
|
Chromosomes, Human, Pair 4 | 2 | 2006 | 377 | 0.030 |
Why?
|
Nerve Tissue Proteins | 1 | 2008 | 4408 | 0.030 |
Why?
|
Alcoholism | 1 | 2005 | 1961 | 0.030 |
Why?
|
Genotype | 5 | 2012 | 12957 | 0.030 |
Why?
|
Lod Score | 2 | 2006 | 602 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2006 | 7022 | 0.030 |
Why?
|
Genome-Wide Association Study | 2 | 2012 | 12628 | 0.020 |
Why?
|
Sex Distribution | 2 | 2006 | 2294 | 0.020 |
Why?
|
China | 2 | 2006 | 2339 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 12914 | 0.020 |
Why?
|
Gene Frequency | 2 | 2008 | 3613 | 0.020 |
Why?
|
Genetic Markers | 2 | 2006 | 2609 | 0.020 |
Why?
|
Pharmacogenetics | 1 | 2012 | 680 | 0.020 |
Why?
|
Costa Rica | 1 | 2007 | 177 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 1683 | 0.020 |
Why?
|
Alleles | 2 | 2012 | 6900 | 0.020 |
Why?
|
Smoking | 1 | 2004 | 9073 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2006 | 6015 | 0.020 |
Why?
|
Language Tests | 1 | 2006 | 190 | 0.020 |
Why?
|
Obesity | 1 | 2008 | 12919 | 0.020 |
Why?
|
Linguistics | 1 | 2006 | 106 | 0.020 |
Why?
|
Taiwan | 1 | 2006 | 505 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2006 | 419 | 0.020 |
Why?
|
Phonetics | 1 | 2006 | 198 | 0.020 |
Why?
|
Phosphofructokinase-1 | 1 | 2004 | 51 | 0.010 |
Why?
|
Phosphofructokinase-2 | 1 | 2004 | 32 | 0.010 |
Why?
|
Hexokinase | 1 | 2004 | 125 | 0.010 |
Why?
|
Phenotype | 3 | 2007 | 16548 | 0.010 |
Why?
|
Nuclear Family | 1 | 2004 | 313 | 0.010 |
Why?
|
Phenylalanine Hydroxylase | 1 | 2002 | 28 | 0.010 |
Why?
|
Male | 11 | 2012 | 359718 | 0.010 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 2002 | 127 | 0.010 |
Why?
|
Pyruvate Kinase | 1 | 2004 | 190 | 0.010 |
Why?
|
Semantics | 1 | 2006 | 599 | 0.010 |
Why?
|
Female | 11 | 2012 | 391246 | 0.010 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2002 | 375 | 0.010 |
Why?
|
Principal Component Analysis | 1 | 2004 | 939 | 0.010 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2002 | 430 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2006 | 2852 | 0.010 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2002 | 534 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2005 | 1174 | 0.010 |
Why?
|
Humans | 14 | 2012 | 760613 | 0.010 |
Why?
|
Functional Laterality | 1 | 2006 | 2253 | 0.010 |
Why?
|
Brain | 1 | 2006 | 26951 | 0.010 |
Why?
|
Haplotypes | 1 | 2005 | 2764 | 0.010 |
Why?
|
Adult | 6 | 2012 | 220007 | 0.010 |
Why?
|
Child, Preschool | 2 | 2012 | 42056 | 0.010 |
Why?
|
Age of Onset | 1 | 2004 | 3302 | 0.010 |
Why?
|
Child | 3 | 2012 | 79799 | 0.010 |
Why?
|
Adolescent | 3 | 2012 | 87809 | 0.010 |
Why?
|
Linear Models | 1 | 2006 | 5877 | 0.010 |
Why?
|
Middle Aged | 5 | 2012 | 220359 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2006 | 2782 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2012 | 15840 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2004 | 4286 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2006 | 12159 | 0.010 |
Why?
|
Sex Factors | 1 | 2006 | 10546 | 0.010 |
Why?
|
Computer Simulation | 1 | 2005 | 6218 | 0.010 |
Why?
|
Prognosis | 1 | 2012 | 29661 | 0.010 |
Why?
|
Gene Expression | 1 | 2004 | 7587 | 0.010 |
Why?
|
Age Factors | 1 | 2008 | 18413 | 0.010 |
Why?
|
Software | 1 | 2005 | 4419 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 24102 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2008 | 25941 | 0.000 |
Why?
|
Infant | 1 | 2008 | 36053 | 0.000 |
Why?
|
Young Adult | 1 | 2012 | 58748 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2012 | 64981 | 0.000 |
Why?
|
Cohort Studies | 1 | 2008 | 41337 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2008 | 58980 | 0.000 |
Why?
|
Risk Factors | 1 | 2004 | 74333 | 0.000 |
Why?
|
Aged | 1 | 2008 | 169143 | 0.000 |
Why?
|